The relationship between chronic obstructive pulmonary disease and transcatheter aortic valve implantation-A systematic review and meta-analysis

Objective The present study was performed to investigate the relationship between chronic obstructive pulmonary disease (COPD) and transcatheter aortic valve implantation (TAVI). Background: Controversies regarding the relationship between COPD and TAVI have intensified. Methods: A literature review...

Full description

Saved in:
Bibliographic Details
Published inCatheterization and cardiovascular interventions Vol. 87; no. S1; pp. 570 - 578
Main Authors Liao, Yan-Biao, He, Ze-Xia, Zhao, Zhen-Gang, Wei, Xin, Zuo, Zhi-liang, Li, Yi-Jian, Xiong, Tian-Yuan, Xu, Yuan-Ning, Feng, Yuan, Chen, Mao
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.03.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective The present study was performed to investigate the relationship between chronic obstructive pulmonary disease (COPD) and transcatheter aortic valve implantation (TAVI). Background: Controversies regarding the relationship between COPD and TAVI have intensified. Methods: A literature review of the PubMed online database was performed, and articles published between January 1, 2002 and March 20, 2015 were analyzed. Random‐effect and fixed‐effect models were used, depending on the between‐study heterogeneity. Results: A total of 28 studies, involving 51,530 patients, were identified in our review. The burden of COPD ranged from 12.5% to 43.4%, and COPD negatively impacted both short‐term and long‐term all‐cause survival (30 days: odds ratio [OR], 1.43, 95% CI, 1.14–1.79; >2 years: hazard ratio [HR], 1.34, 95% CI, 1.12–1.61). COPD was also associated with increased short‐term and mid‐term cardiac‐cause mortality (30 days: OR, 1.29, 95% CI, 1.02–1.64; 1 year: HR: 1.09, 1.02–1.17). Moreover, COPD (OR, 1.97, 95% CI, 1.29–3.0) predicted post‐TAVI acute kidney disease. Importantly, chronic kidney disease (CKD) (HR, 1.2, 95% CI, 1.1–1.32) and the distance of the 6 minute walk test (6MWT) (HR, 1.16, 1.06–1.27) predicted TAVI futility in patients with COPD. Conclusion: COPD is common among patients undergoing TAVI, and COPD impacts both short‐ and long‐term survival. COPD patients, who had a lower BMI, shorter distance of 6MWT and CKD, were at higher risk for TAVI futility. © 2016 Wiley Periodicals, Inc.
Bibliography:National Natural Science Foundation of China - No. 81370219 and 81400267
ArticleID:CCD26443
ark:/67375/WNG-D95763QS-K
istex:DD414413111EB4E95F7157B33C745EF73DB7F51F
Yan‐biao Liao and Ze‐Xia He contributed equally to the manuscript.
Conflict of interest: Nothing to report.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-4
content type line 23
ObjectType-Undefined-3
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.26443